ImmunSYS™ Inc.

2:00 PM - 2:15 PM, Monday, June 3, 2019 ・ Theater 2
ImmunSYS is a clinical stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products to improve the lives of patients with late-stage metastatic cancers. Our platform technology, YourVaccx™ utilizes a novel combination of the proprietary ANTIGENerator™ energy delivery device system, a proprietary branded formulation of immunotherapeutic drugs, and a proprietary procedure developed by the focal prostate cancer therapy pioneer and inventor of the male lumpectomy, Gary Onik, M.D. No current immunotherapies use this novel combination approach. The new YourVaccx™ immunotherapy is a minimally invasive, outpatient procedure designed to empower the immune system to recognize and selectively attack cancer throughout the body. We are developing this radically new operating system for immunotherapy initially for the treatment of late-stage metastatic prostate cancer with a pipeline of additional development programs for other late-stage metastatic cancers.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
Florida
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
YourVaccx
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
Chairman, President, CEO
ImmunSYS™ Inc.